Gene symbol | Chromo- some |
Coordinates (bp, mm10) | Size (bp) | Strand | Feature Type | Gene name |
---|---|---|---|---|---|---|
Tssr37290 | 4 | 8 | + | TSS region | transcription start site region 37290 | |
Tssr37291 | 4 | 18 | + | TSS region | transcription start site region 37291 | |
4930522O17Rik | 4 | 4919 | + | antisense lncRNA gene | RIKEN cDNA 4930522O17 gene | |
Tssr37292 | 4 | 7 | + | TSS region | transcription start site region 37292 | |
Tssr37293 | 4 | 11 | + | TSS region | transcription start site region 37293 | |
AI427809 | 4 | 8876 | - | lincRNA gene | expressed sequence AI427809 | |
Gm12495 | 4 | 446 | + | pseudogene | predicted gene 12495 | |
D4Mit163 | 4 | 135 | DNA segment | DNA segment, Chr 4, Massachusetts Institute of Technology 163 | ||
Tssr41768 | 4 | 27 | - | TSS region | transcription start site region 41768 | |
Tssr37294 | 4 | 11 | + | TSS region | transcription start site region 37294 | |
Tssr37295 | 4 | 8 | + | TSS region | transcription start site region 37295 | |
Gm12496 | 4 | 2082 | - | lincRNA gene | predicted gene 12496 | |
D4Mit272 | 4 | 176 | DNA segment | DNA segment, Chr 4, Massachusetts Institute of Technology 272 | ||
Tssr41769 | 4 | 11 | - | TSS region | transcription start site region 41769 | |
Tssr41770 | 4 | 13 | - | TSS region | transcription start site region 41770 | |
Gm46858 | 4 | 2676 | - | protein coding gene | predicted gene, 46858 | |
Cpgi14301 | 4 | 1772 | CpG island | CpG island 14301 | ||
Tssr37296 | 4 | 114 | + | TSS region | transcription start site region 37296 | |
Slc44a1 | 4 | 182065 | + | protein coding gene | solute carrier family 44, member 1 | |
Tssr37297 | 4 | 32 | + | TSS region | transcription start site region 37297 | |
Tssr37298 | 4 | 2 | + | TSS region | transcription start site region 37298 | |
Cpgi14302 | 4 | 187 | CpG island | CpG island 14302 | ||
Mopkd1 | 4 | 128 | QTL | modifier of polycystic kidney disease progression 1 | ||
Abbp2 | 4 | 40324229 | QTL | A/J and C57BL/6 blood pressure 2 | ||
nmf111 | 4 | 26052934 | heritable phenotypic marker | neuroscience mutagenesis facility, 111 | ||
Nmf191 | 4 | 32899409 | heritable phenotypic marker | neuroscience mutagenesis facility, 191 | ||
D4Mit111 | 4 | 128 | DNA segment | DNA segment, Chr 4, Massachusetts Institute of Technology 111 | ||
1700060J05Rik | 4 | 1714 | - | antisense lncRNA gene | RIKEN cDNA 1700060J05 gene | |
Tssr41771 | 4 | 25 | - | TSS region | transcription start site region 41771 | |
Tssr37299 | 4 | 6 | + | TSS region | transcription start site region 37299 | |
Tssr37300 | 4 | 6 | + | TSS region | transcription start site region 37300 | |
9130223C08Rik | 4 | 594 | unclassified gene | RIKEN cDNA 9130223C08 gene | ||
Gm33729 | 4 | 46676 | - | lncRNA gene | predicted gene, 33729 | |
Cpgi14303 | 4 | 1168 | CpG island | CpG island 14303 | ||
Tssr37301 | 4 | 61 | + | TSS region | transcription start site region 37301 | |
Tssr37302 | 4 | 45 | + | TSS region | transcription start site region 37302 | |
Fsd1l | 4 | 75538 | + | protein coding gene | fibronectin type III and SPRY domain containing 1-like | |
Tssr37303 | 4 | 14 | + | TSS region | transcription start site region 37303 | |
Tssr41772 | 4 | 11 | - | TSS region | transcription start site region 41772 | |
Skts-fp1 | 4 | -70610548 | QTL | skin tumor susceptibility in FVB and PWK 1 |